Effects of differentiation on the transcriptional regulation of the FGF‐4 gene: Critical roles played by a distal enhancer

Embryonal carcinoma (EC) cells are used widely as a model system for studying the expression of developmentally regulated genes, in particular genes that are regulated at the transcriptional level when EC cells differentiate. This review focuses on the molecular mechanisms that govern the transcription of the fibroblast growth factor‐4 (FGF‐4) gene, which appears to be the first FGF expressed during mammalian development. Interest in this gene has increased considerably with the finding that FGF‐4 is essential for mammalian embryogenesis. The FGF‐4 gene has also generated considerable interest because it is inhibited at the transcriptional level when EC cells undergo differentiation and because this gene is regulated by a powerful distal enhancer located 3 kb downstream of the transcription start site in the last exon of the gene. Hence, study of the FGF‐4 gene is likely to shed light on the molecular mechanisms by which distal enhancers regulate gene expression. In addition to being regulated by the downstream enhancer, the expression of this gene is influenced by a regulatory region located just upstream of the transcription start site, which contains two Sp1 motifs and a CCAAT box motif. Examination of the downstream enhancer has identified three functional cis‐regulatory elements: a high mobility group (HMG) protein binding motif, an octamer binding motif, and an Sp1 motif, which are likely to bind Sox‐2, Oct‐3, and Sp1/Sp3, respectively, in vivo. Interestingly, Sox‐2 and Oct‐3 expression, like FGF‐4 expression, decreases when EC cells differentiate, which suggests that the loss of these transcription factors is responsible, at least in part, for the transcriptional turn‐off of the FGF‐4 gene. In view of these and other findings, we present a model for the differential expression of the FGF‐4 gene that includes not only the contributions of specific transcription factors, but also the contribution of chromatin structure before and after differentiation. Mol. Reprod. Dev. 51:218–224, 1998. © 1998 Wiley‐Liss, Inc.

[1]  M. Grunstein.  Histone function in transcription. , 1990, Annual review of cell biology.

[2]  H. Zoghbi,et al.  Spinocerebellar ataxia type 1. , 1995, Clinical neuroscience.

[3]  C. Isacke,et al.  PC13 embryonal carcinoma‐derived growth factor. , 1984, The EMBO journal.

[4]  A. Rizzino.  Understanding the roles of growth factors in carcinogenesis: modulation of autocrine growth control by differentiation. , 1993, The International journal of developmental biology.

[5]  G. Felsenfeld,et al.  Chromatin as an essential part of the transcriptional mechanim , 1992, Nature.

[6]  H. Schöler,et al.  A family of octamer‐specific proteins present during mouse embryogenesis: evidence for germline‐specific expression of an Oct factor. , 1989, The EMBO journal.

[7]  M. Ptashne,et al.  Transcriptional activation by recruitment , 1997, Nature.

[8]  T. Knobloch,et al.  Regulation of FGF-4 enhancer activity by transcription factor NF-Y. , 1995, Biochemical and biophysical research communications.

[9]  R. Kornberg,et al.  Interplay between chromatin structure and transcription. , 1995, Current opinion in cell biology.

[10]  T. Koda,et al.  An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. , 1994, The Journal of biological chemistry.

[11]  G. Peters,et al.  The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Martin,et al.  Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. , 1992, Development.

[13]  A. Rizzino,et al.  Binding of transcription factors to widely‐separated cis‐regulatory elements of the murine FGF‐4 gene , 1996, Molecular reproduction and development.

[14]  H R Drew,et al.  Principles of sequence-dependent flexure of DNA. , 1986, Journal of molecular biology.

[15]  A. Rizzino,et al.  Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. , 1988, Developmental biology.

[16]  R. Kornberg,et al.  Chromatin structure and transcription. , 1992, Annual review of cell biology.

[17]  R. Schultz.  Regulation of zygotic gene activation in the mouse , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  A. Rizzino,et al.  NF‐Y binds to the CCAAT box motif of the FGF‐4 gene and promotes FGF‐4 expression in embryonal carcinoma cells , 1997, Molecular reproduction and development.

[19]  Jerry L. Workman,et al.  Nucleosome displacement in transcription , 1993, Cell.

[20]  Peter W. J. Rigby,et al.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo , 1990, Nature.

[21]  N. Corbi,et al.  Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. , 1995, Genes & development.

[22]  T. Sugimura,et al.  Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells. , 1988, Biochemical and biophysical research communications.

[23]  A. Rizzino,et al.  Nucleotide sequence of the 5'-flanking region of the mouse k-FGF oncogene exhibits an alternating purine:pyrimidine motif with the potential to form Z-DNA. , 1990, Gene.

[24]  J. T. Kadonaga,et al.  Role of chromatin structure in the regulation of transcription by RNA polymerase II. , 1993, Current opinion in cell biology.

[25]  A. Rizzino,et al.  Transcriptional regulation of the murine k-FGF gene in embryonic cell lines. , 1992, Developmental biology.

[26]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[27]  E. Ziff,et al.  Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells. , 1989, Oncogene research.

[28]  G. Peters,et al.  The mouse homologue of hst/k-FGF: sequence, genome organization and location relative to int-2. , 1989, Nucleic acids research.

[29]  G. Li,et al.  CCAAT box binding protein NF‐Y facilitates in vivo recruitment of upstream DNA binding transcription factors. , 1994, The EMBO journal.

[30]  M. Schweizer,et al.  Cooperative Binding of NF-Y and Sp1 at the DNase I-hypersensitive Site, Fatty Acid Synthase Insulin-responsive Element 1, Located at −500 in the Rat Fatty Acid Synthase Promoter* , 1997, The Journal of Biological Chemistry.

[31]  Y. Arimura,et al.  Regulatory sequences required for hst‐1 expression in embryonal carcinoma cells , 1994, FEBS letters.

[32]  C. Basilico,et al.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer , 1994, Molecular and cellular biology.

[33]  S. Strickland,et al.  Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP , 1980, Cell.

[34]  G. Martin,et al.  Teratocarcinomas and mammalian embryogenesis. , 1980, Science.

[35]  K. Miyagawa,et al.  Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Papaioannou,et al.  Requirement of FGF-4 for postimplantation mouse development , 1995, Science.

[37]  A. Rizzino,et al.  Transcriptional regulation of the murine k‐fgf gene , 1994, Molecular reproduction and development.

[38]  B. Turner.  Decoding the nucleosome , 1993, Cell.

[39]  A. Rizzino,et al.  Effects of oxidation and reduction on the binding of transcription factors to Cis‐regulatory elements located in the FGF‐4 gene , 1996, Molecular reproduction and development.

[40]  B. Turner,et al.  Histone acetylation in chromatin and chromosomes. , 1995, Seminars in cell biology.

[41]  Wiebe Kruijer,et al.  Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells , 1991, Mechanisms of Development.

[42]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Rizzino,et al.  Role of the transcription factor Sox‐2 in the expression of the FGF‐4 gene in embryonal carcinoma cells , 1998, Molecular reproduction and development.

[44]  H. Varmus,et al.  Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Ambrosetti,et al.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites , 1997, Molecular and cellular biology.

[46]  C. Basilico,et al.  Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells , 1990, Molecular and cellular biology.

[47]  M. Beato,et al.  DNA rotational positioning in a regulatory nucleosome is determined by base sequence. An algorithm to model the preferred superhelix. , 1990, Nucleic acids research.

[48]  T. Tsukiyama,et al.  Chromatin remodeling and transcription. , 1997, Current opinion in genetics & development.

[49]  A. Rizzino,et al.  DNA sequence and nucleosome placement on the murine fibroblast growth factor-4 gene. , 1997, DNA Sequence.